Updates on Breast Cancer

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2023 Nov 25

PMID 38001652

Authors

Filippo Pesapane

Luca Nicosia

Enrico Cassano

Affiliations

Soon will be listed here.

Abstract

This collection of 18 articles, comprising 12 original studies, 1 systematic review, and 5 reviews, is a collaborative effort by distinguished experts in breast cancer research, and it has been edited by Dr [...].

References

Pesapane F, Rotili A, Agazzi G, Botta F, Raimondi S, Penco S . Recent Radiomics Advancements in Breast Cancer: Lessons and Pitfalls for the Next Future. Curr Oncol. 2021; 28(4):2351-2372. PMC: 8293249. DOI: 10.3390/curroncol28040217. View

Zhang H, Peng Y . Current Biological, Pathological and Clinical Landscape of HER2-Low Breast Cancer. Cancers (Basel). 2023; 15(1). PMC: 9817919. DOI: 10.3390/cancers15010126. View

Valenzuela-Palomo A, Sanoguera-Miralles L, Bueno-Martinez E, Esteban-Sanchez A, Llinares-Burguet I, Garcia-Alvarez A . Splicing Analysis of 16 ClinVar Variants by Minigene Assays: Identification of Six Likely Pathogenic Variants. Cancers (Basel). 2022; 14(18). PMC: 9496955. DOI: 10.3390/cancers14184541. View

Pesapane F, Suter M, Rotili A, Penco S, Nigro O, Cremonesi M . Will traditional biopsy be substituted by radiomics and liquid biopsy for breast cancer diagnosis and characterisation?. Med Oncol. 2020; 37(4):29. DOI: 10.1007/s12032-020-01353-1. View

Nicosia L, Bozzini A, Penco S, Trentin C, Pizzamiglio M, Lazzeroni M . A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast. Cancers (Basel). 2022; 14(2). PMC: 8773816. DOI: 10.3390/cancers14020370. View

Cohen E, Jayachandran G, Moore R, Cristofanilli M, Lang J, Khoury J . A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix PC1 System. Cancers (Basel). 2022; 14(21). PMC: 9656921. DOI: 10.3390/cancers14215238. View

Galland L, Roussot N, Desmoulins I, Mayeur D, Kaderbhai C, Ilie S . Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer. Cancers (Basel). 2023; 15(4). PMC: 9954086. DOI: 10.3390/cancers15041299. View

Kholod O, Basket W, Mitchem J, Kaifi J, Hammer R, Papageorgiou C . Immune-Related Gene Signatures to Predict the Effectiveness of Chemoimmunotherapy in Triple-Negative Breast Cancer Using Exploratory Subgroup Discovery. Cancers (Basel). 2022; 14(23). PMC: 9735620. DOI: 10.3390/cancers14235806. View

Pesapane F, De Marco P, Rapino A, Lombardo E, Nicosia L, Tantrige P . How Radiomics Can Improve Breast Cancer Diagnosis and Treatment. J Clin Med. 2023; 12(4). PMC: 9963325. DOI: 10.3390/jcm12041372. View

10.

Riaz N, Jeen T, Whelan T, Nielsen T . Recent Advances in Optimizing Radiation Therapy Decisions in Early Invasive Breast Cancer. Cancers (Basel). 2023; 15(4). PMC: 9954587. DOI: 10.3390/cancers15041260. View

11.

Zahari S, Syafruddin S, Mohtar M . Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression. Cancers (Basel). 2023; 15(9). PMC: 10177134. DOI: 10.3390/cancers15092653. View

12.

Monteiro F, Stepanauskaite L, Williams C, Helguero L . SETD7 Expression Is Associated with Breast Cancer Survival Outcomes for Specific Molecular Subtypes: A Systematic Analysis of Publicly Available Datasets. Cancers (Basel). 2022; 14(24). PMC: 9775934. DOI: 10.3390/cancers14246029. View

13.

Safe S, Zhang L . The Role of the Aryl Hydrocarbon Receptor (AhR) and Its Ligands in Breast Cancer. Cancers (Basel). 2022; 14(22). PMC: 9688153. DOI: 10.3390/cancers14225574. View

14.

Yang L, Du W, Hu T, Liu M, Cai L, Liu Q . Survival in Breast Cancer Patients with Bone Metastasis: A Multicenter Real-World Study on the Prognostic Impact of Intensive Postoperative Bone Scan after Initial Diagnosis of Breast Cancer (CSBrS-023). Cancers (Basel). 2022; 14(23). PMC: 9740679. DOI: 10.3390/cancers14235835. View

15.

Derevianko A, Pizzoli S, Pesapane F, Rotili A, Monzani D, Grasso R . The Use of Artificial Intelligence (AI) in the Radiology Field: What Is the State of Doctor-Patient Communication in Cancer Diagnosis?. Cancers (Basel). 2023; 15(2). PMC: 9856827. DOI: 10.3390/cancers15020470. View

16.

Pesapane F, Rotili A, Valconi E, Agazzi G, Montesano M, Penco S . Women's perceptions and attitudes to the use of AI in breast cancer screening: a survey in a cancer referral centre. Br J Radiol. 2022; 96(1141):20220569. PMC: 11864346. DOI: 10.1259/bjr.20220569. View

17.

Cserni B, Kilmartin D, OLoughlin M, Andreu X, Bago-Horvath Z, Bianchi S . ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations. Cancers (Basel). 2023; 15(4). PMC: 9954449. DOI: 10.3390/cancers15041199. View

18.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

19.

Alkhaleefah M, Tan T, Chang C, Wang T, Ma S, Chang L . Connected-SegNets: A Deep Learning Model for Breast Tumor Segmentation from X-ray Images. Cancers (Basel). 2022; 14(16). PMC: 9406420. DOI: 10.3390/cancers14164030. View

20.

Petrillo A, Fusco R, Di Bernardo E, Petrosino T, Barretta M, Porto A . Prediction of Breast Cancer Histological Outcome by Radiomics and Artificial Intelligence Analysis in Contrast-Enhanced Mammography. Cancers (Basel). 2022; 14(9). PMC: 9102628. DOI: 10.3390/cancers14092132. View